Literature DB >> 21138497

The role of observational investigations in comparative effectiveness research.

Nicholas F Marko1, Robert J Weil.   

Abstract

INTRODUCTION: Comparative effectiveness research (CER) seeks to inform clinical decisions between alternate treatment strategies using data that reflects real patient populations and real-world clinical scenarios for the purpose of improving patient outcomes. There are multiple clinical situations where the unique characteristics of observational investigations can inform medical decision-making within the CER paradigm. Accordingly, it is critical for clinicians to appreciate the strengths and limitations of observational research, particularly as they apply to CER.
METHODS: This review focuses on the role of observational research in CER. We discuss the concept of evidence hierarchies as they relate to observational research and CER, review the scope and nature of observational research, present the rationale for its inclusion in CER investigations, discuss potential sources of bias in observational investigations as well as strategies used to compensate for these biases, and discuss a framework to implement observational research in CER.
CONCLUSIONS: The CER paradigm recognizes the limitations of hierarchical models of evidence and favors application of a strength-of-evidence model. In this model, observational research fills gaps in randomized clinical trial data and is particularly valuable to investigate effectiveness, harms, prognosis, and infrequent outcomes as well as in circumstances where randomization is not possible and in studies of many surgical populations. Observational investigations must be designed with careful consideration of potential sources of bias and must incorporate strategies to control such bias prospectively, and their results must be reported in a uniform and transparent fashion. When these conditions can be achieved, observational research represents a valuable and critical component of modern CER.
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Entities:  

Mesh:

Year:  2010        PMID: 21138497     DOI: 10.1111/j.1524-4733.2010.00786.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  10 in total

1.  Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.

Authors:  Stephanie Chen; An-Chen Fu; Rahul Jain; Hiangkiat Tan
Journal:  Am Health Drug Benefits       Date:  2015-04

2.  Enhancing Clinical Content and Race/Ethnicity Data in Statewide Hospital Administrative Databases: Obstacles Encountered, Strategies Adopted, and Lessons Learned.

Authors:  Michael Pine; Niranjana M Kowlessar; Jason L Salemi; Jill Miyamura; David S Zingmond; Nicole E Katz; Joe Schindler
Journal:  Health Serv Res       Date:  2015-06-26       Impact factor: 3.402

3.  Advanced Imaging Reduces Cost Compared to Standard of Care in Emergency Department of Triage of Acute Chest Pain.

Authors:  Pamela S Noack; Jhanna A Moore; Michael Poon
Journal:  Health Serv Res       Date:  2017-11-13       Impact factor: 3.402

4.  Genesis of improved quality in imaging through a national Australian echocardiography registry.

Authors:  David Eccleston; Gregory Scalia; Leighton Kearney; David Cross; Daniel Cehic; Patrick Disney; Xiao-Fang Xu; Peter Cain; Piyush M Srivastava
Journal:  Open Heart       Date:  2022-05

5.  Management patterns of patients with cerebral metastases who underwent multiple stereotactic radiosurgeries.

Authors:  Deborah C Marshall; Logan P Marcus; Teddy E Kim; Brandon A McCutcheon; Steven J Goetsch; Takao Koiso; John F Alksne; Kenneth Ott; Bob S Carter; Jona A Hattangadi-Gluth; Masaaki Yamamoto; Clark C Chen
Journal:  J Neurooncol       Date:  2016-03-07       Impact factor: 4.130

Review 6.  Translating rare-disease therapies into improved care for patients and families: what are the right outcomes, designs, and engagement approaches in health-systems research?

Authors:  Beth K Potter; Sara D Khangura; Kylie Tingley; Pranesh Chakraborty; Julian Little
Journal:  Genet Med       Date:  2015-04-09       Impact factor: 8.822

7.  Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry.

Authors:  Emma Gray; David J Pasta; Suzanne Norris; Aisling O'Leary
Journal:  BMC Health Serv Res       Date:  2017-04-19       Impact factor: 2.655

8.  Systematic review of endovascular stent grafting versus open surgical repair for the elective treatment of arch/descending thoracic aortic aneurysms.

Authors:  Andrew McCarthy; Joanne Gray; Priya Sastry; Linda Sharples; Luke Vale; Andrew Cook; Peter Mcmeekin; Carol Freeman; Pedro Catarino; Stephen Large
Journal:  BMJ Open       Date:  2021-03-04       Impact factor: 2.692

9.  Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data.

Authors:  Simone Ghislandi; Aleksandra Torbica; Giuseppe Boriani
Journal:  BMC Health Serv Res       Date:  2013-03-15       Impact factor: 2.655

Review 10.  Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review.

Authors:  Timor Faber; Philippe Ravaud; Carolina Riveros; Elodie Perrodeau; Agnes Dechartres
Journal:  BMC Med Res Methodol       Date:  2016-03-22       Impact factor: 4.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.